Caribbean International Holdings, Inc. (CIHN: OTC Pink

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Caribbean International Holdings, Inc. (CIHN: OTC Pink Current) | Caribbean International Holdings (CIHN) Announces Deal With Executive Services Consultant; Long Time Industry Insider to Help Steer Company During This Stage of Expansion; Will Provide Day-to-Day Executive Services Assistance for Company

SARASOTA, Fla., May 14, 2014 (GLOBE NEWSWIRE) -- Caribbean International Holdings (Pink Sheets:CIHN) through its subsidiary, Regenerative BioScience, Inc., ("RBS") announced today that it was close to completing its search to acquire the services of an experienced consultant to provide executive services assistance to the Company's Board & Officers to help lead the Company into and through this period of expected expansion of the company's assets, maximize revenue, brand the Company's services and increase shareholder value.

The candidate is a long time industry insider and a turnaround specialist who has acted as Chairman, General Counsel, CEO and/or President, at various times, of a number of emerging public companies.

Steven Swank, Chairman and CEO of Caribbean International Holdings, stated, "He has specific experience with companies that are at our company's stage of development."

"In fact, he and I are planning to meet with the Dr. Leonel Liriano, the Company's Medical Director and the Company's Advisory Board Member, Rafael Gonzalez, Ph.D. , on May 15th to the 17 th , when Dr. Gonzalez will be a guest speaker at the 22nd Annual World Congress on ANTI-AGING, REGENERATIVE & AESTHETIC MEDICINE, in Orlando, Florida. It will give him a chance to plan the Company's next steps, map out its short and long time visions and to learn the history of the Company, meet its key players and to establish a bond between them so that together, they can move the company forward."

"We plan to close the deal before or at the meeting. I'm 71 years old and I look forward to stepping back and begin winding down."

The candidate has extensive experience in mergers & acquisitions, negotiations, licensing (worldwide) and celebrity endorsements. He is adept at building brands and brand awareness. He has, and will, act as the liaison between the Board of Directors/Officers and all outside counsel from corporate to litigation to SEC.

He is especially effective in the area of shareholder/investor relations, an excellent writer, with a strong corporate, marketing & legal background. In the public companies he was involved in, he also wrote their press releases.

Mr. Swank went on to say: "He is experienced in increasing shareholder value and effectively communicating the company's vision to investors, shareholders and potential customers alike. He has recently been a consultant to several public companies as a legal liaison between their Boards and Officers and the respective companies' outside SEC, Litigation and General Counsels, and have served as a consultant, advisor, officer and director of various emerging companies in the technology, medical device and direct response industries to help steer them through the process to becoming publicly traded.

Mr. Swank added: "In another good sign of the public awareness of the Company's services, company reports of patient applications show that 50% new patient applications originate through Company's website & 50% from word of mouth. I feel this is a wonderful trend that we hope continues."

About The Company:

Caribbean International Holdings, Inc. is a holding company for Regenerative Bio Science, Inc. ("RBSI"). The Company subsidiary RBSI is focused on helping individuals to protect and ensure their future quality of life through Adult Stem Cell Incubation and the practice of regenerative medicine in the United States and the Dominican Republic. RBSI's mission is not only to allow patients to store their Stem Cells for future use, but also perform patient funded stem cell therapies for degenerative diseases such as MS, Arthritis, Degenerative Heart Diseases, Diabetes and a host of experimental therapies in the brain trauma disease sector including CTE. The goal is to become a global leader in establishing protocols that can be patented and utilized to heal patients around the world.

Adult stem cells work as the repairmen of the body by replenishing and regenerating damaged tissues and cells. Certain conditions have shown marked improvement when treated with adult stem cells taken from the patient's own body. Regenerative BioScience is a revolution in healthcare using a patient's own adult stem cells.

For more information go to: http://www.regenerativebioscience.com/index.html

About: Dr. Leonel Liriano

Leonel Francisco Liriano Espinal is a graduate of the Medical School of Medicine Technical University of Santiago (UTESA). Dr. Liriano has specialized as an intensive care physician at St. Joseph Hospital in the city of Santiago de Chile, and has also been prepared in Clinical Nutrition for Critical Patient in the Auxilio Mutuo Hospital, in the city of Santurce, Puerto Rico, as well as studied Intensive Post-operative Cardiovascular at Cedars Hospital in the City of Miami, Florida and trainings in Neurocritical care in NYU Hospital, New York City.

Twelve years ago while talking to a surgeon who practiced in Germany, Dr. Liriano, who is professor of cardiology and intensive care at the Technological University of Santiago (UTES), became interested in the process of cell therapy and how this could serve as hope to treat diseases without possibility of cure. Since then, Dr. Liriano along with his team of doctors from different specialties has successfully applied the stem cell-based therapy to more than 1000 people. This includes 200 sports figures; with the most prominent being baseball player Bartolo Colon for whom he was the lead physician.

Bartolo Colon was out of baseball for nearly 2 years because of a serious shoulder injury, but returned to the sport and became an All-Star thanks to a stem cell procedure where stem cells were taken from his body and then re-injected into his shoulder by Dr. Liriano. This injury previously may have required surgery to be repaired or the player would be forced into early retirement. This life changing procedure may now have the potential to extend athletes careers and shorten rehabilitation time.

About: Rafael Gonzalez, Ph.D.

Dr. Gonzalez has expertise in degenerative disorders involving the spinal cord and has extensive experience in stem cell culture and biology from human embryonic, pre-natal and adult sources. Prior to joining DaVinci Biosciences, Dr. Gonzalez served as a Research Scientist at PrimeGen Biotech where he was responsible for the design and execution of experiments involving adult (bone marrow, menstrual blood, adipose) and pre-natal stem cells (neural, bone marrow, liver, gonadal) for potential clinical application. Dr. Gonzalez was also responsible for developing PrimeGen's pre-clinical stem cell/spinal cord injury model.

Dr. Gonzalez developed his thesis at the Reeve-Irvine Research Center, University of California, Irvine, under the advisory of Dr. Hans Keirstead, entitled: "The Role of the Chemokine CXCL10 in Secondary Degeneration Following Spinal Cord Injury". Pre-clinical studies conducted during this time lead by Dr. Gonzalez were aimed at reducing secondary degenerative effects. The studies conducted by Dr. Gonzalez and Dr. Keirstead precipitated the start-up of Ability Biomedical, a company that developed anti-IP10 antibody, an antibody which can be used to treat several degenerative disorders such as multiple sclerosis, rheumatoid arthritis, and SCI. Ability Biomedical was purchased by Medarex in 2007 which was purchased by Bristol-Myers Squibb that sponsors a phase II clinical trial using anti-IP10 antibody (MDX-1100). He also was involved with preclinical studies in the development of the use of human embryonic stem cells into spinal cord injury.

Dr. Gonzalez has several scientific publications in the field of stem cells, spinal cord injury and the immune system.

Dr. Gonzalez received his BS in Biological Science and his Ph.D. in Anatomy and Neurobiology from the University of California, Irvine, CA .

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available on at http://www.sec.gov .

 CONTACT: Investor Contact:           BioScience           (941) 924-9400 
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 150

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 122

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 304

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 201

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: C3.ai Faces Class Action Over Financial Disclosures

Updated Category News Views 198

Investors Alert Regarding Class Action Lawsuit Against C3.ai NEW YORK and NEW ORLEANS — Investors of C3.ai, Inc. are encouraged to act swiftly regarding a class action lawsuit. If you have experienced losses exceeding $100,000 and purchased the company’s securities between February 26, 2025, and August 8, 2025, you may be eligible to participate as lead plaintiff in...

Continue Reading
XCMG's Global Expansion: Building Bridges Down Under and Beyond

Updated Category News Views 58

Trade Missions and Machinery: A Strategic Move Trade winds are blowing from Xuzhou to Jakarta and Sydney, with XCMG Group's top brass spearheading efforts. Chairman Yang Dongsheng and his band of delegates are making big waves, strengthening ties with Indonesia and Australia. Now, any seasoned trader will tell you to keep an eye on these moves—it's all about setting the...

Continue Reading
Local Expertise Wins in Luxury Real Estate Market

Updated Category News Views 48

Why Local Expertise Still Matters Technology has transformed how we shop for real estate, but when it comes to luxury, Jud Whitlock isn't buying the idea that local knowledge doesn't matter. This guy's been around the block, and in a recent HelloNation piece, he dropped some truths that every global buyer and seller ought to take to heart. If you're thinking a snazzy app...

Continue Reading
Hewlett Packard Enterprise's Bold Move with AI Day and Juniper

Updated Category News Views 90

Hewlett Packard Enterprise Sets the Stage for AI Day with Exciting Developments Hewlett Packard Enterprise Co (HPE) is making headlines as it sets out on an ambitious path by acquiring Juniper Networks for a significant $14 billion. This pivotal acquisition underscores the company's commitment to advancing its position in the technology market, particularly in the realms...

Continue Reading
BRT Realty Trust Achieves 52-Week Milestone: Here’s What It Means

Updated Category News Views 153

BRT Realty Trust: A Closer Look at Recent Success Recently, BRT Realty Trust (NYSE: BRT) made headlines by hitting a remarkable 52-week high, with shares trading at $20.12. This achievement signifies a strong upward trend for the real estate investment trust, particularly known for its focus on multi-family properties. In the past year alone, BRT Realty Trust has seen its...

Continue Reading